Publication:
Gamma knife radiosurgery in patients with Cushing's disease: comparison of aggressive pituitary corticotroph tumor versus corticotroph adenoma

dc.contributor.coauthorKara, Müjdat
dc.contributor.coauthorGüdük, Mustafa
dc.contributor.coauthorYılmaz, Meltem
dc.contributor.coauthorŞengöz, Meriç
dc.contributor.departmentSchool of Medicine
dc.contributor.kuauthorPeker, Selçuk
dc.contributor.kuauthorSamancı, Mustafa Yavuz
dc.contributor.schoolcollegeinstituteSCHOOL OF MEDICINE
dc.date.accessioned2024-11-09T22:58:59Z
dc.date.issued2020
dc.description.abstractAggressive pituitary corticotroph tumors causing Cushing's disease are rare, and there is limited data about their clinical management. Here, we aimed to report our long-term experience with gamma knife radiosurgery (GKRS) as adjuvant treatment in patients with residual or recurrent pituitary corticotroph tumors. This retrospective study included 45 adult patients (M/F, 7/38; mean age, 40.2 +/- 13.1 years) with residual tumor or recurrence after initially successful surgical resection. Single-session GKRS was performed in all patients. Tumors with a Ki-67 value higher than 3 % and radiologic invasion to surrounding tissues were classified as aggressive tumor group. Clinical, hormonal and radiological findings were compared between the aggressive (n = 10) and non-aggressive adenoma (n = 35) groups. Following GKRS, tumor volumes were significantly reduced in both groups. The mean time to hormonal remission in the non-aggressive group was significantly shorter than in the aggressive group (23.5 +/- 6.3 vs 33.0 +/- 5.0 month, respectively, p < 0.05). New-onset hypopituitarism was identified in only seven patients (15 %) after GKRS in the whole cohort. The present study introduces several essential findings about aggressive corticotroph tumors. First, aggressive behavior tends to occur more frequently in male subjects. Second, time to GKRS was significantly shorter in the aggressive group. Moreover, a tumor volume >= 2 cm(3) may be associated with clinical aggressiveness in corticotroph tumors. In conclusion, we suggest that early adjuvant GKRS is an effective treatment option in aggressive pituitary corticotroph tumors.
dc.description.indexedbyWOS
dc.description.indexedbyScopus
dc.description.indexedbyPubMed
dc.description.openaccessNO
dc.description.sponsoredbyTubitakEuN/A
dc.description.volume197
dc.identifier.doi10.1016/j.clineuro.2020.106151
dc.identifier.eissn1872-6968
dc.identifier.issn0303-8467
dc.identifier.scopus2-s2.0-85089956462
dc.identifier.urihttps://doi.org/10.1016/j.clineuro.2020.106151
dc.identifier.urihttps://hdl.handle.net/20.500.14288/7815
dc.identifier.wos582523600045
dc.keywordsCushing's disease
dc.keywordsGamma knife radiosurgery
dc.keywordsKi-67
dc.keywordsPituitary tumor
dc.keywordsHypopituitarism
dc.language.isoeng
dc.publisherElsevier
dc.relation.ispartofClinical Neurology and Neurosurgery
dc.subjectClinical neuropsychology
dc.subjectSurgery
dc.titleGamma knife radiosurgery in patients with Cushing's disease: comparison of aggressive pituitary corticotroph tumor versus corticotroph adenoma
dc.typeJournal Article
dspace.entity.typePublication
local.contributor.kuauthorSamancı, Mustafa Yavuz
local.contributor.kuauthorPeker, Selçuk
local.publication.orgunit1SCHOOL OF MEDICINE
local.publication.orgunit2School of Medicine
relation.isOrgUnitOfPublicationd02929e1-2a70-44f0-ae17-7819f587bedd
relation.isOrgUnitOfPublication.latestForDiscoveryd02929e1-2a70-44f0-ae17-7819f587bedd
relation.isParentOrgUnitOfPublication17f2dc8e-6e54-4fa8-b5e0-d6415123a93e
relation.isParentOrgUnitOfPublication.latestForDiscovery17f2dc8e-6e54-4fa8-b5e0-d6415123a93e

Files